# Clindamycin phosphate

NDC: 0338-3814
Generic name: Clindamycin phosphate
Labeler / Manufacturer: Baxter Healthcare Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20170628

FDA application: ANDA208084

## Active ingredients

- CLINDAMYCIN PHOSPHATE: 900 mg/50mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0338-3814"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0338-3814
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=78832ac6-04c5-45e0-ae4d-f56d7920dda9